The investigation of chlamydia trachomatis in clinical samples with molecular methods

Chlamydia trachomatis is known as the most common bacterial infection agent to pass with sexual transition. This microorganism is an obligatory intracellular parasite. C. trachomatis causes eye infections such as trachoma, pneumonias in new born babies, genito urinary system infections and Lymphogranuloma venereum (LGV) that is constituted by LGV strains causes pathology in the lymph nodes in the genital region. In this study, it has been aimed to investigate C. trachomatis by using polymerase chain reaction (PCR) and real time PCR methods. The swab samples that have been taken from 50 patients, who have applied to Erciyes University Gevher Nesibe Investigation and Application Hospital Obstetric and Gynecology Policlinics and Urology Policlinics with genital flow pre-diagnosis between February 2010 and March 2010 dates, have been included in this study. C. trachomatis was found positive in 1 (2%) sample of 50 samples. As a conclusion no difference was found between two PCR methods for investigation of C. trachomatis DNA.

PDF

___

1.Gates W, Wasseheit JN. Genital chlamydia infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164: 1771.
2. Bilgehan H. Klinik Mikrobiyoloji Özel Bakteriyoloji ve Bakteri Enfeksiyonları. Barış Yayınları Fakülteler Kitapevi, İzmir, 1990.
3. Tosun İ, Şanlıdağ T, Akçalı S, et al. Reaktif artritli hastalarda Chlamydia trachomatis’ in araştırılması. Türk Mikrobiyoloji Cemiyeti Dergisi 2005; 35: 25-30.
4. Öztürk M, Selçukbiricik S. Mikrobiyoloji ve İmmunoloji. Nobel Tıp Kitabevleri, İstanbul, 2000; p: 88-90.
5. Serter D. Mikrobiyoloji ve Enfeksiyon Hastalıkları. Nobel Tıp Kitabevleri, İzmir, 1997; 21: 193-198.
6. Serter D. Mikrobiyoloji. Saray Tıp Kitabevleri, İzmir, 1992; 15: 169-172.
7. Hills SD, A Nakasima PA, Machbanks DG, et al. Risk factors for recurrent C.trachomatis infections in women. Am J Obstet Gynecol 1994; 170: 801-806.
8. Zhang JP, Stephens RS. Mechanism of C. trachomatis attachment to eucaryotice host cell. Cell 1992; 89:881-889.
9. Orr P, Sherman E, Blanchard J, et al. Epidemiology of infection due to Chlamydia trachomatis in Manitoba. Canada, Clin Infect Dis 1994; 19: 876-883.
10. Cheng H, Macaluso M, Vermund SH, et al. Relative accuracy of nucleic acid amplification test and culture in detecting Chlamydia in asymptomatic Men. J Clin Mic 2001;3927- 3937.
11. Ferrero DV, Meyers HN, Schultz DE, et al. Performance of the Gen-Probe AMPLIFIED Chlamydia trachomatis assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending Sexually Transmitted Disease and Family Planning Clinics. J Clin Microbiol 1998; 3230-3233.
12. Olafsson JH, Davidsson S, Karlsson SM, et al. Diagnosis of Chlamydia trachomatis infection in high-risk females with PCR on first void urine. Acta Derm Venereol 1996; 76: 226- 227.
13. Germain M, Alary M, Guedeme A, et al. Eva- luation of a screening algorithm for he diag- nosis of genital infections with Neisseria go- norrhoeae and Chlamydia trachomatis among female sexworkers in Benin. Sex Transm Dis 1997; 24: 109-115.
14. Goessens WH, Mouton JW, van der Meijden WI, et al. Comparison of three commercially available amplification assays, AMP CT, LCx and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first void urine. J Clin Microbiol 1997; 35: 2628-2633.
15. Puolakkainen M, Hiltunen-Back E, Reunala T, et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol 1998; 36: 4489-4493.